Menu
close
The aim of the DZL Biobanking Platform is the SOP-based acquisition, processing, collection, and storage of biomaterial as well as the collection of associated clinical data from the most diverse pulmonary disease areas in compliance with all necessary legal standards. Both scientists within the DZL and external cooperation partners should be able to access biomaterial and data easily and in compliance with the rules. In terms of quality management, the harmonization of ethical and legal documents, data protection concepts, and standard operating procedures associated with quality control and data management is a key objective of all DZL sites.
Prof. Dr. Andreas Günther (UGMLC)
Dr. Thomas Muley (TLRC)
Dr. Jutta Schlegel (UGMLC)
Dr. Clemens Ruppert (UGMLC)
Raphael Majeed (UGMLC)
Theis and colleagues have shown how data from individual blood stem cells can be used to determine their fate...
DZL PI Prof. Dr. Roland Eils receives the Heidelberg Molecular Life Sciences Investigator Award.
The new DZL- initiated registry for “Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases” (in short “EXCITING”) is now recruiting.
